|
C1GALT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.7553000000008E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.077540E-03 |
| Normal-vs-Stage2 |
2.617200E-01 |
| Normal-vs-Stage3 |
4.362700E-03 |
| Normal-vs-Stage4 |
1.354030E-04 |
| Stage1-vs-Stage2 |
3.948600E-01 |
| Stage1-vs-Stage3 |
4.480400E-01 |
| Stage1-vs-Stage4 |
1.430620E-01 |
| Stage2-vs-Stage3 |
2.701600E-01 |
| Stage2-vs-Stage4 |
7.979800E-02 |
| Stage3-vs-Stage4 |
6.484600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.164700E-04 |
| Normal-vs-AfricanAmerican |
5.90780000031543E-07 |
| Normal-vs-Asian |
9.631800E-01 |
| Caucasian-vs-AfricanAmerican |
1.827810E-02 |
| Caucasian-vs-Asian |
4.087000E-01 |
| AfricanAmerican-vs-Asian |
3.079900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.41119999999651E-06 |
| Normal-vs-Female |
7.775800E-02 |
| Male-vs-Female |
1.351980E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.407500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.375800E-04 |
| Normal-vs-Age(61-80Yrs) |
2.519300E-03 |
| Normal-vs-Age(81-100Yrs) |
3.896000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.839000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.653600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.850200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.425200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.123400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.367000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.218400E-02 |
| Normal-vs-Grade 2 |
2.389700E-02 |
| Normal-vs-Grade 3 |
2.23179999999656E-05 |
| Normal-vs-Grade 4 |
1.384090E-04 |
| Grade 1-vs-Grade 2 |
7.612800E-01 |
| Grade 1-vs-Grade 3 |
9.083200E-01 |
| Grade 1-vs-Grade 4 |
6.166400E-01 |
| Grade 2-vs-Grade 3 |
1.961450E-01 |
| Grade 2-vs-Grade 4 |
7.939500E-02 |
| Grade 3-vs-Grade 4 |
3.489200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.060360E-01 |
| Normal-vs-ccB subtype |
5.258700E-03 |
| ccA subtype-vs-ccB subtype |
1.732800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.920050E-02 |
| Normal-vs-N1 |
3.390400E-01 |
| N0-vs-N1 |
8.682800E-01 |
|
|
